KAMAL KISHORE SHARMA

      DIN: 00209430

      For latest information about the director, visit MCA.

      KAMAL KISHORE SHARMA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 00209430. KAMAL KISHORE SHARMA is/has been associated with 23 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      TEMPLECRAFT REALTY LLP Designated Partner 20-Oct-2014
      TEMPLERIVIERE PROPERTY LLP Designated Partner 20-Oct-2014
      ASSETZ BUILDWELL LLP Partner 19-Aug-2015
      TEMPLE WELLNESS VENTURES LLP Designated Partner 16-Oct-2015
      SHILPA MEDICARE LIMITED Director 01-Jul-2022
      SEQUENT SCIENTIFIC LIMITED Director 17-Jan-2021
      SYMED LABS LIMITED Director 01-Dec-2022
      VIYASH LIFE SCIENCES PRIVATE LIMITED Director 01-Dec-2022
      LUPIN PHARMACARE LIMITED Director 21-Aug-2007
      FAISA FINANCIAL P LTD Director 07-Aug-1991
      TEMPLETREE PROPERTIES PRIVATE LIMITED Director 18-Jan-2006
      ALIVIRA ANIMAL HEALTH LIMITED Director 14-Sep-2020
      TEMPLE WELLNESS VENTURES INDIA PRIVATE LIMITED Director 27-Apr-2017

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      LUPIN LIMITED Director 29-Sep-2018 14-Oct-2022
      LUPIN LIMITED Managing Director 25-Aug-2003 01-Sep-2013
      LUPIN LIMITED Whole-time director 29-Sep-2015 29-Sep-2018
      SHILPA MEDICARE LIMITED Additional Director 01-Jul-2022 28-Sep-2022
      SEQUENT SCIENTIFIC LIMITED Additional Director 25-Aug-2020 17-Jan-2021
      LUPIN DIAGNOSTICS LIMITED Additional Director 26-Aug-2011 23-Jul-2012
      LUPIN DIAGNOSTICS LIMITED Director 23-Jul-2012 21-Nov-2022
      SYMED LABS LIMITED Additional Director 01-Dec-2022 26-Dec-2022
      VIYASH LIFE SCIENCES PRIVATE LIMITED Additional Director 01-Dec-2022 26-Dec-2022
      ALIVIRA ANIMAL HEALTH LIMITED Additional Director 09-Sep-2020 14-Sep-2020

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales